Gates grant bolsters study of Tdap boosters in pregnant women
Jul. 9, 2015—Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.
VU study explores optimal timing for pertussis vaccine
Feb. 12, 2015—Pertussis, commonly known as whooping cough, is experiencing a resurgence, and its tiniest victims are not armed to battle the contagious respiratory infection.